{"id":53514,"date":"2023-09-20T09:47:08","date_gmt":"2023-09-20T09:47:08","guid":{"rendered":"https:\/\/medsname.com\/thalix\/"},"modified":"2026-04-30T16:30:28","modified_gmt":"2026-04-30T16:30:28","slug":"thalix","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ro\/product\/thalix\/","title":{"rendered":"Thalix"},"content":{"rendered":"<div class=\"medsbase-tldr-answer\" style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:14px 18px;margin:18px 0;border-radius:4px;\">\n<h3 style=\"margin-top:0;\">R\u0103spuns rapid<\/h3>\n<p style=\"margin-bottom:0;\"><strong>Thalix<\/strong> \u2014 Thalidomide 50\/100 mg (produc\u0103tor certificat WHO-GMP). IMiD de prima genera\u021bie \u2014 pentru mielom multiplu, eritem nodos lepros (reac\u021bie de tip 2 la lepr\u0103) \u0219i afec\u021biuni inflamatorii refractare. Notoriu teratogen \u2014 program obligatoriu de preven\u021bie a sarcinii.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f7f7f7;border-left:4px solid #2c7cb0;padding:14px 18px;margin:18px 0;border-radius:4px;\">\n<p style=\"margin:0 0 6px 0;\"><strong>Ce beneficii ofer\u0103 MedsBase:<\/strong><\/p>\n<ul style=\"margin:6px 0 0 22px;padding:0;list-style:disc;\">\n<li>produc\u0103tor certificat WHO-GMP<\/li>\n<li>Ambalaj discret \u00een plic simplu<\/li>\n<li>Livrare \u00een toat\u0103 lumea<\/li>\n<li>Evaluat de peste 1.400 de clien\u021bi (<a href=\"https:\/\/medsbase.com\/ro\/reviews\/\">cite\u0219te recenziile<\/a>)<\/li>\n<\/ul>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"background:#eef7ee;border-left:4px solid #4caf50;padding:10px 14px;margin:14px 0;border-radius:3px;\">\ud83d\udce6 <strong>Garan\u021bia de retransmitere:<\/strong> dac\u0103 comanda dvs. nu a ajuns \u00een 20 de zile lucr\u0103toare de la expediere, o retransmitem f\u0103r\u0103 costuri suplimentare. <a href=\"https:\/\/medsbase.com\/ro\/medsbase-re-shipment-assurance-policy\/\">Cite\u0219te politica<\/a>.<\/p>\n<h3>De ce s\u0103 comanzi de la MedsBase<\/h3>\n<p>Thalix este expediat de la un produc\u0103tor certificat WHO-GMP \u00een ambalaj neutru, facturat prin procesator de plat\u0103 reglementat (descrierea extrasului de cont indic\u0103 un procesator de pl\u0103\u021bi cu card reglementat \u2014 niciodat\u0103 MedsBase sau nume de medicament). Fiecare comand\u0103 beneficiaz\u0103 de Asigurarea noastr\u0103 de Retrimitere \u00een 20 de zile lucr\u0103toare.<\/p>\n<div class=\"medsbase-specialist-strip\" style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 18px;margin:18px 0;border-radius:4px;\">\n<p style=\"margin:0;\"><strong>\u26a0\ufe0f Terapie oncologic\u0103 supravegheat\u0103 de specialist<\/strong> \u2014 acest medicament este ini\u021biat, monitorizat \u0219i \u00eentrerupt de un oncolog sau hematolog. Dozarea depinde de tipul tumorii, stadiul, suprafa\u021ba corporal\u0103, func\u021bia organelor \u0219i terapia concomitant\u0103. Autotratamentul nu este adecvat; informa\u021biile de mai jos au scop educa\u021bional \u0219i sus\u021bin conversa\u021biile informate cu specialistul dumneavoastr\u0103.<\/p>\n<\/div>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:12px 16px;margin:14px 0;border-radius:3px;\"><strong>Avertisment de graviditate \u00een cutie neagr\u0103 \u2014 program strict de prevenire<\/strong><br \/>Toate IMiD-urile sunt puternic teratogene (talidomida fiind cea mai notorie \u2014 focomelie). Program obligatoriu de prevenire a sarcinii (echivalent REMS\/iCare): teste de sarcin\u0103 \u00eenainte, \u00een timpul \u0219i dup\u0103; dou\u0103 metode contraceptive eficiente; consiliere pentru ambii parteneri; interzicerea don\u0103rii de s\u00e2nge \u00een timpul terapiei sau 4 s\u0103pt\u0103m\u00e2ni dup\u0103. Chiar \u0219i o singur\u0103 doz\u0103 \u00een timpul sarcinii poate provoca malforma\u021bii severe.<\/div>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:12px 16px;margin:14px 0;border-radius:3px;\"><strong>Risc de TEV \u2014 tromboprofilaxie<\/strong><br \/>IMiD-urile prezint\u0103 risc crescut de tromboz\u0103 venoas\u0103 profund\u0103 \u0219i embolie pulmonar\u0103, mai ales \u00een combina\u021bie cu corticosteroizi sau doxorubicin\u0103. Tromboprofilaxie obligatorie: aspirin\u0103 \u00een doze mici (risc sc\u0103zut) sau HBPM\/warfarin\u0103\/DOAC (pacien\u021bi cu risc crescut). Stabilit\u0103 de specialist.<\/div>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:12px 16px;margin:14px 0;border-radius:3px;\"><strong>Specific Thalidomide: neuropatie periferic\u0103 + sedare<\/strong><br \/>Thalidomida provoac\u0103 neuropatie periferic\u0103 dependent\u0103 de doz\u0103 (adesea ireversibil\u0103) \u0219i sedare semnificativ\u0103. Administra\u021bi seara. Reevalua\u021bi neuropatia la fiecare vizit\u0103; \u00eentrerupe\u021bi sau reduce\u021bi doza dac\u0103 apare neuropatie de grad 2+. Evita\u021bi la pacien\u021bii cu neuropatie semnificativ\u0103 preexistent\u0103.<\/div>\n<h2 id=\"faqs\">\u00centreb\u0103ri frecvente<\/h2>\n<h3>C\u00e2nd se utilizeaz\u0103?<\/h3>\n<p>IMiD de prima genera\u021bie \u2014 pentru mielom multiplu, eritem nodos lepros (reac\u021bie de tip 2 la lepr\u0103) \u0219i afec\u021biuni inflamatorii refractare. Notoriu teratogen \u2014 program obligatoriu de preven\u021bie a sarcinii.<\/p>\n<h3>Cum se administreaz\u0103?<\/h3>\n<p>O dat\u0103 pe zi, de obicei \u00een cicluri (de ex., 21 de zile de tratament, 7 zile pauz\u0103 pentru lenalidomid\u0103). Doza \u0219i programul specifice sunt determinate de protocolul pentru mielom (Rd, RVd, KRd etc.). Stabilite de specialist \u00een func\u021bie de r\u0103spunsul tumoral \u0219i tolerabilitate.<\/p>\n<h3>Prevenirea sarcinii?<\/h3>\n<p>Program obligatoriu: teste de sarcin\u0103 lunare, dou\u0103 metode contraceptive eficiente, contracep\u021bie pentru partener, consiliere. Chiar \u0219i o singur\u0103 doz\u0103 \u00een timpul sarcinii poate provoca malforma\u021bii severe. Interzicerea don\u0103rii de s\u00e2nge \u00een timpul terapiei \u0219i pentru 4 s\u0103pt\u0103m\u00e2ni dup\u0103 \u00eentrerupere.<\/p>\n<h3>Efecte secundare frecvente?<\/h3>\n<p>Clasa IMiD: TEV, oboseal\u0103, erup\u021bii cutanate, probleme gastrointestinale (constipa\u021bie, diaree), mielosupresie. Lenalidomida: mai pu\u021bin\u0103 neuropatie dec\u00e2t talidomida. Pomalidomida: de obicei mai bine tolerat\u0103 dec\u00e2t talidomida; mai pu\u021bin afectare renal\u0103. Talidomida: neuropatie periferic\u0103, sedare.<\/p>\n<h3>Interac\u021biuni medicamentoase?<\/h3>\n<p>Anticoagulante \u2014 ajustate \u00een func\u021bie de strategia de profilaxie a TEV. Nivelurile de digoxin\u0103 pot cre\u0219te. Agen\u021bi eritropoietinici + IMiD \u2014 risc crescut de tromboz\u0103; utiliza\u021bi numai cu profilaxie antitrombotica obligatorie.<\/p>\n<h3>Monitorizare renal\u0103?<\/h3>\n<p>Lenalidomida: ajustarea dozei \u00een func\u021bie de CrCl (acumulare renal\u0103 semnificativ\u0103). Pomalidomida: efect renal redus, dar monitorizare necesar\u0103. Talidomida: metabolit eliminat renal \u2014 monitorizare func\u021bie renal\u0103.<\/p>\n<h3>Ce fac dac\u0103 uit o doz\u0103?<\/h3>\n<p>Lua\u021bi doza dac\u0103 v\u0103 aminti\u021bi \u00een decurs de &lt;12 ore; altomi\u021bi sari\u021bi \u0219i relua\u021bi tratamentul \u2014 nu lua\u021bi o doz\u0103 dubl\u0103. Anun\u021ba\u021bi echipa de oncologie dac\u0103 au fost omise mai multe doze.<\/p>\n<h3>Vaccinare?<\/h3>\n<p>Vaccinuri inactivate permise; vaccinuri vii contraindicate \u00een timpul terapiei cu IMiD. Optimiza\u021bi vaccin\u0103rile \u00eenainte de \u00eenceperea tratamentului, dac\u0103 posibil.<\/p>\n<h3>Complica\u021bii pe termen lung?<\/h3>\n<p>Terapie IMiD: neoplasme primare secundare (\u00een special la utilizarea prelungit\u0103), risc cumulativ de TEV, neuropatie (talidomida \u00een special).<\/p>\n<h3>C\u00e2nd se \u00eentrerupe tratamentul?<\/h3>\n<p>Stabilit de specialist: durata r\u0103spunsului, toxicitate, pauz\u0103 planificat\u0103 \u00een tratament, trecere la terapia de men\u021binere. Terapia de men\u021binere cu IMiD este acum standard \u00een mielom \u2014 de obicei lenalidomid\u0103 post-transplant de celule stem autologe continuat\u0103 timp de 2-3 ani sau p\u00e2n\u0103 la intoleran\u021b\u0103.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h2>Alte Medicamente Anticanceroase<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/ro\/xeloda\/\">Xeloda<\/a> \u2014 capecitabin\u0103 500 mg \u2014 prodrog oral de 5-FU pentru cancerul de s\u00e2n\/colorectal\/gastric<\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/altraz\/\">Altraz<\/a> \u2014 anastrozol 1 mg \u2014 inhibitor de aromataz\u0103 pentru cancerul de s\u00e2n la femei postmenopauzale<\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/xbira\/\">Xbira<\/a> \u2014 abirateron\u0103 250 mg \u2014 inhibitor CYP17 pentru cancerul metastatic de prostat\u0103<\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/zoldria\/\">Zoldria<\/a> \u2014 acid zoledronic IV \u2014 pentru metastaze osoase \u0219i hipercalcemie<\/li>\n<li><a href=\"https:\/\/medsbase.com\/ro\/actorise\/\">Actorise<\/a> \u2014 darbepoetin alfa \u2014 pentru anemie indus\u0103 de chimioterapie<\/li>\n<\/ul>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:12px 16px;margin:18px 0;border-radius:3px;font-size:.95em;\"><strong>Disclaimer medical:<\/strong> Tratamentul cancerului este foarte individualizat. Medicamentul specific, doza, programul, monitorizarea \u0219i \u00eengrijirea de sus\u021binere trebuie stabilite de un oncolog sau hematolog calificat, pe baza biologiei tumorii, stadializ\u0103rii, comorbidit\u0103\u021bilor \u0219i obiectivelor terapiei. Aceast\u0103 informa\u021bie are caracter educa\u021bional; nu \u00eenlocuie\u0219te sfatul medical profesionist.<\/div>","protected":false},"excerpt":{"rendered":"<p>Thalix (Thalidomide 50\/100 mg) \u2014 IMiD de prima genera\u021bie pentru mielom multiplu \u0219i eritem nodos lepros. Notoriu teratogen; necesit\u0103 preven\u021bie strict\u0103 a sarcinii.<\/p>","protected":false},"featured_media":53515,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3595,3141,3223],"product_tag":[],"class_list":{"0":"post-53514","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-anti-cancer-medication","7":"product_cat-category-overview","8":"product_cat-chronic-conditions","10":"first","11":"outofstock","12":"shipping-taxable","13":"purchasable","14":"product-type-variable","15":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product\/53514","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/comments?post=53514"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media\/53515"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/media?parent=53514"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_brand?post=53514"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_cat?post=53514"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ro\/wp-json\/wp\/v2\/product_tag?post=53514"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}